Aim: To report a case where application of the French regulation on drug imports impeached in France the use of a French registered drug. Case-report: The authors were not allowed by the French Drug Agency (AFSSaPS) to use a French registered drug which was no more available in France but in Sweden. Discussion: The authors emphasize on inconsistencies of the regulations on drug imports and on its application by the French Drug Agency. Conclusion: Clarification of European regulations regarding drug circulation within Europe is waited.